Medicare Evaluation Tool | Pulmonary

A – Disabling dyspnea at rest, poor or unresponsive to bronchodilators, resulting in decreased functional capacity (e.g., bed-to-chair existence, fatigue, and cough.) Documentation of FEV1, after bronchodilator, less than 30% of predicted is objective evidence for disabling dyspnea, but is not required.
B – Progression of end stage pulmonary disease, as evidenced by increasing ER visits or hospitalizations for pulmonary infections and/or respiratory failure or increased physician home visits prior to initial certification. Documentation of serial decrease of FEV1>40ml a year is objective evidence of disease progression, but is not required.

Diagnosis: Pulmonary Disease